Published in Hepatitis Weekly, June 24th, 2002
Doctors in the Netherlands have reported observing more cases of hyperfibrinolysis among their liver transplant recipients who received treated plasma than among those who received fresh frozen plasma. Follow-up studies conducted by those physicians suggest the virus inactivation process, consisting of a solvent/detergent treatment procedure known as ESDEP, was the source of their observations.
ESDEP is used for ridding blood products of viral contaminants...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.